Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HON
9. HTZ
10. JPM

Go back to Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs

Cocrystal Pharma, Inc. (COCP) Misses Q2 EPS by 21c

August 15, 2022 8:04 AM EDT

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q2 EPS of ($0.25), $0.21 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

... More